Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abdulrahman Alhajahjeh"'
Autor:
Abdulrahman Alhajahjeh, Majedah Hmeidan, Mus'ab Elatrsh, Faris Al-Abbadi, Diala Kakish, Razan Sukerji, Mohammad Salah, Bashir Al Hussein Al Awamlh, David I. Lee, Mohammed Shahait
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEClinical trials are valuable evidence for managing urologic malignancies. Early termination of clinical trials is associated with a waste of resources and may substantially affect patient care. We sought to study the termination rate of urolog
Externí odkaz:
https://doaj.org/article/f60afb7bcfa64471881222a8634e160f
Autor:
Abdulrahman Alhajahjeh, Raad Al-Faouri, Hisham F. Bahmad, Taima’ Bader, Ryan W. Dobbs, Ahmed A. Abdulelah, Wassim Abou-Kheir, Elai Davicioni, David I. Lee, Mohammed Shahait
Publikováno v:
Cancers, Vol 16, Iss 8, p 1538 (2024)
Glucagon-like peptide-1 (GLP-1), an incretin hormone renowned for its role in post-meal blood sugar regulation and glucose-dependent insulin secretion, has gained attention as a novel treatment for diabetes through GLP-1 receptor agonists (GLP-1-RA).
Externí odkaz:
https://doaj.org/article/b7b8d9802353406db5a1dac16a66a9f0
Autor:
Hikmat Abdel-Razeq, Rawan Mustafa, Sarah Abdel-Razeq, Hala Abu-Fares, Sama Al Masri, Rana Damsees, Mariam El-Atrash, Shatha Elemian, Mais Alkyam, Khawlah Ammar, Rayan Bater, Marah Kderat, Abdulrahman Alhajahjeh
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Background: Breast cancer susceptibility genes such as BRCA1, BRCA2, PALB2, CHEK2 and many others are increasingly recognized among our patient population. In addition to their impact on treatment decisions of tested patients themselves, identifying
Externí odkaz:
https://doaj.org/article/8969c859312547a493dd135867181475
Autor:
Randa Farah, Abdulrahman Alhajahjeh, Amani Nofal, Tala Basheer Hyasat, Raghed Abdel Hay Abu Jabeh, Lojayn Tareq Suboh, Hussam Alhawari, Munther S. Momani, Hazem Jamal Jaber, Izzat AlAwwa
Publikováno v:
Journal of Diabetes and its Complications. 37:108478